Nicaraven
未知生产厂商
Nicaraven is presently being developed for the treatment of cerebral stroke including subarachnoid hemorrhage. This drug is promising because some data suggest it to have an ability to scavenge the hydroxyl radical under physiological conditions in vivo, while it also has a high permeability through the blood brain barrier.
Investigated for use/treatment in cerebrovascular disease (unspecified).
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
